Andre Feldman Selected Research

Respiratory Insufficiency (Respiratory Failure)

1/2020

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andre Feldman Research Topics

Disease

2	COVID-19 01/2022 - 01/2020
1	Hypertensive Crisis 01/2020
1	Transient Ischemic Attack 01/2020
1	Heart Failure 01/2020
1	Myocarditis (Carditis) 01/2020
1	Pericarditis 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Stroke (Strokes) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Myocardial Infarction 01/2020
1	Abdominal Aortic Aneurysm 01/2019
1	Ischemia 05/2017
1	Atrial Fibrillation 05/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2017
1	Wounds and Injuries (Trauma) 05/2017
1	Inflammation (Inflammations) 05/2017

Drug/Important Bio-Agent (IBA)

2	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	TroponinIBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020
1	ConnexinsIBA 05/2017
1	RNA (Ribonucleic Acid)IBA 05/2017

Therapy/Procedure

2	Braces 01/2022 - 01/2020
1	Therapeutics 01/2020
1	Length of Stay 05/2017
1	Sutures (Suture) 05/2017